Co-expression of fatty acid synthase and caveolin-1 in pancreatic ductal adenocarcinoma: implications for tumor progression and clinical outcome - PubMed
Co-expression of fatty acid synthase and caveolin-1 in pancreatic ductal adenocarcinoma: implications for tumor progression and clinical outcome
Agnieszka K Witkiewicz et al. Cell Cycle. 2008 Oct.
Abstract
Pancreatic cancer is a devastating disease that afflicts over 35,000 Americans every year. Since therapeutic options are limited, understanding the molecular aspects of this disease is critical for moving towards targeted treatment of this aggressive form of cancer. Caveolin-1 (Cav-1) and fatty acid synthase (FASN) are two proteins that have been shown to be dysregulated in a number of cancers. Functionally these proteins have been shown to be involved in the process of tumorigenesis. We thus surveyed the expression of both these critical proteins in a series of pancreatic precancerous lesions (pancreatic intraepithelial neoplasia, PanIN) and pancreatic cancers. Cav-1 and FASN expression correlated predominantly with clinical characteristics, such as histologic grade and advanced tumor stage (e.g., high Cav-1 and FASN expression correlated with poor differentiation status) and a significant survival advantage was found in patients with low co-expressing FASN and Cav-1 tumors. Cav-1 and FASN expression was absent in PanIN lesions and the normal ducts and acini. Of note, Cav-1 expression was detected in the fibroblasts of the desmoplastic pancreatic cancer stroma, but not in stromal cells of the normal pancreas. Mechanistically, these data support the notion that these proteins are co-regulated either directly or indirectly by another factor. Importantly, the co-expression of these proteins significantly correlates with clinical features and survival status of pancreatic cancer patients. Thus, Cav-1 and FASN may functionally cooperate in the process of pancreatic tumorigenesis, and as such, may be good candidate prognostic markers and targets for therapeutic intervention.
Similar articles
-
Bian Y, Yu Y, Wang S, Li L. Bian Y, et al. Biochem Biophys Res Commun. 2015 Aug 7;463(4):612-7. doi: 10.1016/j.bbrc.2015.05.108. Epub 2015 Jun 2. Biochem Biophys Res Commun. 2015. PMID: 26043686
-
Di Vizio D, Sotgia F, Williams TM, Hassan GS, Capozza F, Frank PG, Pestell RG, Loda M, Freeman MR, Lisanti MP. Di Vizio D, et al. Cancer Biol Ther. 2007 Aug;6(8):1263-8. doi: 10.4161/cbt.6.8.4447. Epub 2007 May 17. Cancer Biol Ther. 2007. PMID: 17786030
-
Tanase CP, Dima S, Mihai M, Raducan E, Nicolescu MI, Albulescu L, Voiculescu B, Dumitrascu T, Cruceru LM, Leabu M, Popescu I, Hinescu ME. Tanase CP, et al. J Mol Histol. 2009 Feb;40(1):23-9. doi: 10.1007/s10735-008-9209-7. Epub 2009 Jan 22. J Mol Histol. 2009. PMID: 19160064
-
Caveolin-1: a marker for pancreatic cancer diagnosis.
Tanase CP. Tanase CP. Expert Rev Mol Diagn. 2008 Jul;8(4):395-404. doi: 10.1586/14737159.8.4.395. Expert Rev Mol Diagn. 2008. PMID: 18598222 Review.
-
Pancreatic intraepithelial neoplasia revisited and updated.
Sipos B, Frank S, Gress T, Hahn S, Klöppel G. Sipos B, et al. Pancreatology. 2009;9(1-2):45-54. doi: 10.1159/000178874. Epub 2008 Dec 12. Pancreatology. 2009. PMID: 19077454 Review.
Cited by
-
Elevated expression of stromal palladin predicts poor clinical outcome in renal cell carcinoma.
Gupta V, Bassi DE, Simons JD, Devarajan K, Al-Saleem T, Uzzo RG, Cukierman E. Gupta V, et al. PLoS One. 2011;6(6):e21494. doi: 10.1371/journal.pone.0021494. Epub 2011 Jun 28. PLoS One. 2011. PMID: 21738681 Free PMC article.
-
Shan T, Lu H, Ji H, Li Y, Guo J, Chen X, Wu T. Shan T, et al. PLoS One. 2014 Jun 20;9(6):e97239. doi: 10.1371/journal.pone.0097239. eCollection 2014. PLoS One. 2014. PMID: 24949874 Free PMC article.
-
Lipid metabolism reprogramming and its potential targets in cancer.
Cheng C, Geng F, Cheng X, Guo D. Cheng C, et al. Cancer Commun (Lond). 2018 May 21;38(1):27. doi: 10.1186/s40880-018-0301-4. Cancer Commun (Lond). 2018. PMID: 29784041 Free PMC article. Review.
-
Metabolism addiction in pancreatic cancer.
Blum R, Kloog Y. Blum R, et al. Cell Death Dis. 2014 Feb 20;5(2):e1065. doi: 10.1038/cddis.2014.38. Cell Death Dis. 2014. PMID: 24556680 Free PMC article. Review.
-
A Fatty Acid Synthase Inhibitor Shows New Anticancer Mechanisms.
Bueno MJ, Colomer R. Bueno MJ, et al. EBioMedicine. 2015 Aug;2(8):778-779. doi: 10.1016/j.ebiom.2015.08.023. Epub 2015 Aug 14. EBioMedicine. 2015. PMID: 28087115 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous